FOLH1 and prostate cancer: In this study, we evaluate the image quality of delayed [68 Ga]Ga-PSMA-11 LFOV PET/CT and examine the feasibility of utilizing delayed [68 Ga]Ga-PSMA-11 LFOV PET/CT imaging alone in patients with prostate cancer.